Shenzhen Bioeasy Biotechnology Co., Ltd.

SZSE:300942 Stock Report

Market Cap: CN¥3.3b

Shenzhen Bioeasy Biotechnology Valuation

Is 300942 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300942 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 300942's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 300942's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300942?

Key metric: As 300942 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 300942. This is calculated by dividing 300942's market cap by their current revenue.
What is 300942's PS Ratio?
PS Ratio13.3x
SalesCN¥247.06m
Market CapCN¥3.29b

Price to Sales Ratio vs Peers

How does 300942's PS Ratio compare to its peers?

The above table shows the PS ratio for 300942 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average7.6x
300981 Zhonghong Pulin Medical Products
2.5x10.2%CN¥6.0b
688151 Hubei Huaqiang High-Tech
10.2xn/aCN¥5.6b
688606 Hangzhou Alltest Biotech
6.4xn/aCN¥5.2b
688399 Jiangsu Bioperfectus Technologies
11.3xn/aCN¥4.5b
300942 Shenzhen Bioeasy Biotechnology
13.3xn/aCN¥3.3b

Price-To-Sales vs Peers: 300942 is expensive based on its Price-To-Sales Ratio (13.3x) compared to the peer average (7.6x).

Price to Sales Ratio vs Industry

How does 300942's PS Ratio compare vs other companies in the CN Medical Equipment Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
002382 Blue Sail MedicalLtd
0.9xn/aUS$745.21m
300358 Truking Technology
0.8x10.9%US$615.54m
No more companies available in this PS range
300942 13.3xIndustry Avg. 6.1xNo. of Companies11PS03.67.210.814.418+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 300942 is expensive based on its Price-To-Sales Ratio (13.3x) compared to the CN Medical Equipment industry average (6.3x).

Price to Sales Ratio vs Fair Ratio

What is 300942's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300942 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio13.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 300942's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.0b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.32

7D

-6.6%

1Y

-29.4%

Truking Technology

CN¥4.5b

Engages in medical equipment business in China and internationally.

300358

CN¥7.54

7D

-6.6%

1Y

-36.9%

Chison Medical Technologies

CN¥2.8b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥24.86

7D

-7.0%

1Y

-45.4%